The applicant commits to the continuation of all on-going stability studies under long term conditions up
to the 48 month time point. In addition, stability studies will be carried out on 3 early commercial batches
of naloxegol under long term, intermediate, and accelerated conditions. Furthermore, at least 1
commercial batch per year will be placed on a long-term stability study.